PURPLE BIOTECH LTD's ticker is PPBT and the CUSIP is 74638P109. A total of 19 filers reported holding PURPLE BIOTECH LTD in Q3 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $43,120 | -16.1% | 30,800 | +5.5% | 0.00% | – |
| Q1 2023 | $51,392 | -75.3% | 29,200 | -80.6% | 0.00% | – |
| Q4 2022 | $207,690 | +2.8% | 150,500 | +51.4% | 0.00% | – |
| Q3 2022 | $202,000 | -1.9% | 99,400 | +15.6% | 0.00% | – |
| Q2 2022 | $206,000 | -47.6% | 85,961 | -13.3% | 0.00% | – |
| Q1 2022 | $393,000 | -60.9% | 99,097 | -61.6% | 0.00% | – |
| Q4 2021 | $1,006,000 | -11.7% | 258,050 | +3.3% | 0.00% | – |
| Q3 2021 | $1,139,000 | -22.2% | 249,700 | -16.8% | 0.00% | – |
| Q2 2021 | $1,464,000 | +219.7% | 300,000 | +170.8% | 0.00% | – |
| Q1 2021 | $458,000 | +189.9% | 110,800 | +167.9% | 0.00% | – |
| Q4 2020 | $158,000 | – | 41,358 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 346,197 | $1,319,000 | 0.01% |
| Virtu Financial LLC | 22,988 | $88,000 | 0.01% |
| WASHINGTON TRUST BANK | 16,454 | $63,000 | 0.01% |
| TRUE Private Wealth Advisors | 6,700 | $25,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 28,800 | $110,000 | 0.00% |
| Your Advocates Ltd., LLP | 400 | $2,000 | 0.00% |
| Renaissance Technologies | 128,900 | $491,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| North Star Investment Management Corp. | 300 | $1,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 26,167 | $100,000 | 0.00% |